RMTI — Rockwell Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $58.21m
- $59.80m
- $83.61m
- 13
- 53
- 60
- 37
Annual cashflow statement for Rockwell Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.1 | -30.9 | -32.7 | -18.7 | -8.44 |
| Depreciation | |||||
| Non-Cash Items | 8.06 | 3.37 | 3.31 | 3.3 | 4.83 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.98 | -2.96 | -4.84 | -2.61 | -7.24 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -27.3 | -29.6 | -33.5 | -17.4 | -9.41 |
| Capital Expenditures | -0.587 | -1.05 | -0.522 | -0.281 | -12.6 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -4.16 | 4.26 | 0.833 | -2.12 | 9.6 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.75 | 3.21 | 0.311 | -2.4 | -3.04 |
| Financing Cash Flow Items | -2.08 | -3.89 | -0.006 | -0.191 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 21.1 | 63.3 | -2.18 | 16.6 | 11.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.9 | 36.9 | -35.4 | -3.18 | -1.12 |